menu
    • menu
    [{"orgOrder":0,"company":"TOYO Pharmaceutical","sponsor":"PharmaMar","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"","productType":"Small molecule","year":"2020","type":"Licensing Agreement","leadProduct":"Trabectedin","moa":"","graph1":"Oncology","graph2":"Approved","graph3":"TOYO Pharmaceutical","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Infusion","sponsorNew":"TOYO Pharmaceutical \/ TOYO Pharmaceutical","highestDevelopmentStatusID":"12","companyTruncated":"TOYO Pharmaceutical \/ TOYO Pharmaceutical"}]

    Find Clinical Drug Pipeline Developments & Deals by TOYO Pharmaceutical

    Menu

    TOYO Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            TOYO Pharmaceutical

                            Japan arrow
                            Medlab Asia & Asia Health
                            Not Confirmed

                            TOYO Pharmaceutical

                            Japan arrow
                            Medlab Asia & Asia Health
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Trabectedin

                            Therapeutic Area : Oncology

                            Study Phase : Approved

                            Recipient : PharmaMar

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Taiwan Toyo Obtains Exclusive License for New Soft Tissue Sarcoma Drug Yondelis® in Taiwan, Hong Kong and Mac...

                            Details : Under the agreement, Taiwan Toyo will distribute the new anti-cancer drug Yondelis (trabectedin), a newly synthesized anti-tumor drug derived from the sea squirt Ecteinascidia turbinata, in Taiwan, Hong Kong and Macau.

                            Brand Name : Yondelis

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            June 09, 2020

                            Lead Product(s) : Trabectedin

                            Therapeutic Area : Oncology

                            Highest Development Status : Approved

                            Recipient : PharmaMar

                            Deal Size : Undisclosed

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth